Objective:

To investigate the association between retinal vein occlusion (RVO) and the risk of systemic adverse events such as stroke and myocardial infarction.

Key Findings:

• Patients with BRVO and CRVO have an increased risk of systemic adverse events, including heart attack, ischemic and hemorrhagic stroke, and carotid disease.
• Higher frequency of anti-VEGF injections correlates with an increased likelihood of heart attack.

Interpretation:

The presence of RVO may serve as an additional risk factor for systemic health issues, necessitating closer monitoring and management of cardiovascular risk factors in affected patients.

Limitations:

• The study is hypothesis-generating and may not establish causation.
• The use of cataract patients as a control group may not fully account for all confounding variables.

Conclusion:

Patients with retinal vein occlusions should be monitored for systemic health risks, and healthcare providers should ensure follow-up with primary care and cardiology to manage modifiable risk factors.